Wasp venom from Vespa magnifica acts as a neuroprotective agent to alleviate neuronal damage after stroke in rats

Pharm Biol. 2022 Dec;60(1):334-346. doi: 10.1080/13880209.2022.2032207.

Abstract

Context: Acute ischaemic stroke (AIS) is a major cause of disability and death, which is a serious threat to human health and life. Wasp venom extracted from Vespa magnifica Smith (Vespidae) could treat major neurological disorders.

Objective: This study investigated the effects of wasp venom on AIS in rats.

Material and methods: We used a transient middle cerebral artery occlusion (MCAO) model in Sprague-Dawley rats (260-280 g, n = 8-15) with a sham operation group being treated as negative control. MCAO rats were treated with wasp venom (0.05, 0.2 and 0.6 mg/kg, i.p.) using intraperitoneal injection. After treatment 48 h, behavioural tests, cortical blood flow (CBF), TTC staining, H&E staining, Nissl staining, TUNEL assay, immunohistochemistry (IHC) and ELISA were employed to investigate neuroprotective effects of wasp venom.

Results: Compared with the MCAO group, wasp venom (0.6 mg/kg) improved neurological impairment, accelerated CBF recovery (205.6 ± 52.92 versus 216.7 ± 34.56), reduced infarct volume (337.1 ± 113.2 versus 140.7 ± 98.03) as well as BBB permeability as evidenced by changes in claudin-5 and AQP4. In addition, function recovery of stroke by wasp venom treatment was associated with a decrease in TNF-α, IL-1β, IL-6 and inhibition activated microglia as well as apoptosis. Simultaneously, the wasp venom regulated the angiogenesis factors VEGF and b-FGF in the brain.

Conclusions: Wasp venom exhibited a potential neuroprotective effect for AIS. In the future, we will focus on determining whether the observed actions were due to a single compound or the interaction of multiple components of the venom.

Keywords: Ischaemic stroke; brain–blood barrier; neuroinflammation.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Brain Ischemia / drug therapy*
  • Dose-Response Relationship, Drug
  • Infarction, Middle Cerebral Artery
  • Ischemic Stroke / drug therapy*
  • Male
  • Neurons / drug effects
  • Neurons / pathology
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Wasp Venoms / administration & dosage
  • Wasp Venoms / pharmacology*
  • Wasps

Substances

  • Neuroprotective Agents
  • Wasp Venoms

Grants and funding

This work was supported by the National Natural Science Foundation of China [grant number: 82160798, 81703742 and 81360679], the Natural Science Foundation of Yunnan Province [grant number: 2019FB121], the Special Program of Science and Technology of Yunnan Province [202002AA100007].